Article
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
10 Nov 2018
Abstract excerpt
Alloimmune risk stratification in renal transplantation has lacked the necessary prognostic biomarkers to personalize recipient care or optimize clinical trials. HLA molecular mismatch improves precision compared to traditional antigen mismatch but has not been studied in detail at the individual molecule level. This study evaluated 664 renal transplant recipients and correlated HLA-DR/DQ single molecule eplet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
